|
NicOx And Ferrer Present Promising Clinical And Preclinical Results In Dermatology (Medical News Today)
NicOx S.A. (Eurolist: COX) announced the presentation of promising clinical and preclinical results from its collaboration with Ferrer Grupo International at the 21st World Congress of Dermatology, in Buenos Aires, Argentina. [click link for full article]
Lure of sun gets some students hooked (The Miami Hurricane)
Leisurely exposing oneself to the sun's mighty rays is a staple of the Sunshine State. But when the effects of tanning begin to raise a sun lover's risk of cancer, it makes some think twice about going under the rays.
Put the kettle on: Tea is steeped in health benefits (USA Today)
How refreshing. Tea, something that people around the world enjoy consuming, might actually be good for you. "The most fascinating thing is, to my knowledge, there is no other natural product known that has such diversified effects," says Hasan Mukhtar, vice chair of dermatology at the University of Wisconsin-Madison.
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy (Marketwire via Yahoo! Finance)
DUSA Pharmaceuticals, Inc.® -
Abbott's ABT-874 Shows Positive Results For Maintenance Of Response In Phase II Psoriasis Study (Medical News Today)
Results from an extension to a Phase II study evaluating the effectiveness of Abbott's investigational anti-IL-12/23 antibody ABT-874 showed that a majority of patients who initially responded to treatment maintained a high level of response following discontinuation of therapy. [click link for full article]
Injecting beauty in the burbs (The Sun Chronicle)
NORFOLK - Don't call him a Botox doc. Pushing Dr. Dave David - once a doctor to the stars and now a Norfolk single father - into that, or any one category, wouldn't be fair. He's got much bigger things on his agenda.
Shire Sells 8 Products for $213 Million (AP via Yahoo! Finance)
Drug developer Shire Plc. said Monday it will sell dermatology products Solaraze and Vaniqa, and six other products to Almirall for $213 million.
Service takeover to go ahead (Newham Recorder)
THE dermatology and rheumatology service takeover at Newham General Hospital will now definitely take place on November 1, a hospital chief has said.
Face or bottom: can a woman have it all? (Times Online Sunday)
Every woman eventually has to choose: a youthful face or a pert behind. Fashion editor Lisa Armstrong opts for the former
Shire Divests Non-Core Product Portfolio to Almirall (PR Newswire via Yahoo! Finance)
Shire plc , the global specialty biopharmaceutical company, announces that it has agreed to sell a portfolio of non core products to Almirall for a cash consideration of $213m. The portfolio includes the dermatology products, SOLARAZE® and VANIQA® , and six other non-promoted products1 across a range of indications, which are principally sold by Shire in the UK, France, Germany, Italy, Spain ...
Back to Dermatology
Back to Dermatology News Archives |
adsense code |